Faculty profile

Sudeep Shivakumar

ResearcherMedicineDalhousie University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses and email address may be missing. Find their university profile.

Sudeep Shivakumar

Researcher

Medicine

Health Sciences

Dalhousie University

Halifax, Nova Scotia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
23 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,290

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hematology Hip Arthroplasty Knee Arthroplasty Orthopedic Surgery Randomized Controlled Trial Thrombosis Venous Thromboembolism

Latest papers

Primary thromboprophylaxis in patients with malignancy and central venous catheters: TRIM-Line randomized controlled trial - Design and rationale.
Thrombosis and haemostasis · 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
New England Journal of Medicine · 2026
The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolism
Research and Practice in Thrombosis and Haemostasis · 2026

All 44 publications

Latest funding

EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty
CIHR · 2019 · Nominated PI
$4,482,900

All 1 grants and awards

44 publications.

Primary thromboprophylaxis in patients with malignancy and central venous catheters: TRIM-Line randomized controlled trial - Design and rationale.

Wang TF, Ikesaka R, Mahé I, Hill D, Sperlich C, Tagalakis V, Shivakumar S, Leonard B, Cervi A, Kuruvilla P, Larose F, Matino D, Frosi Stella S, Séguin C, Al Raizah A, Le Gal G, Siegal DM, Delluc A, Mallick R, Lazo-Langner A, Wu C, Christopher D, Di Nisio M, Ageno W, Yazji B, Carrier M

Thrombosis and haemostasis2026

DOI: 10.1055/a-2963-4656 PMID: 42767263

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

Castellucci LA, Chen VM, Kovacs MJ, Lazo-Langner A, Greenstreet P, Kahn S, Côté B, Schulman S, de Wit K, Douketis J

New England Journal of Medicine202652 citations

DOI: 10.1056/nejmoa2510703

The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolism

Martens ESL, Mai V, Bates V, Delluc A, Girard P, Huisman MV, Kahn SR, Kearon C, Kovacs MJ, Pecarskie A

Research and Practice in Thrombosis and Haemostasis2026

DOI: 10.1016/j.rpth.2026.106617

Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism

Mai V, Martens ESL, Righini M, Schulman S, Thiruganasambandamoorthy V, Bates V, Pecarskie A, Kovacs MJ, Visser S, Shivakumar S

Research and Practice in Thrombosis and Haemostasis2026

DOI: 10.1016/j.rpth.2026.103442

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Wang T, Yeo E, Gross PL, Séguin C, Wu C, Shivakumar S, Mallick R, Delluc A, D'Astous J, Kimpton M

American Journal of Hematology2026

DOI: 10.1002/ajh.70127

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty

Shivakumar S, Matino D, Zukor D, Kahn SR, Vincent G, Mundi R, Vendittoli P-A, Refaei M, Bohm E, Tanzer M

New England Journal of Medicine2026First author

DOI: 10.1056/nejmoa2603649

Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey.

Delluc A, Carrier M, Lauw M, Cuker A, Bertoletti L, Beyer-Westendorf J, Di Nisio M, Simard C, Roberge G, Harrigan A, Shivakumar S, Skeith L, Ageno W, Riva N

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis2025

DOI: 10.1097/mbc.0000000000001388 PMID: 41065579

Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study

Mai V, Martens ESL, Righini M, Schulman S, Thiruganasambandamoorthy V, Kahn SR, Pecarskie A, Kovacs MJ, Visser S, Shivakumar S

Journal of Thrombosis and Haemostasis20257 citations

DOI: 10.1016/j.jtha.2025.06.019

Validation of the ToDay, a simplified diagnostic algorithm for deep vein thrombosis

Sharma S, Soon L, de Wit K, Sharma S, Afilalo M, Le Gal G, Shivakumar S, Bates SM, Wu C, Lazo-Langner A

Journal of Thrombosis and Haemostasis20253 citations

DOI: 10.1016/j.jtha.2025.06.029

TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.

Abdulrehman J, Harrigan A, Simard C, Tagalakis V, Shivakumar S

Thrombosis research2024Senior author

DOI: 10.1016/j.thromres.2024.01.009 PMID: 38262288

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2019

Subject: Prospective PhD student: Hematology Dear Professor Shivakumar, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Primary thromboprophylaxis in patients with malignancy and central venous catheters: TRIM-Line randomized controlled trial - Design and rationale." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty" (2019), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Sudeep Shivakumar

Research

Latest papers

Latest funding

Primary thromboprophylaxis in patients with malignancy and central venous catheters: TRIM-Line randomized controlled trial - Design and rationale.

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

The diagnostic performance of the YEARS and Pulmonary Embolism Graduated D-dimer algorithms in patients with prior venous thrombosis suspected of pulmonary embolism

Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty

Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey.

Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study

Validation of the ToDay, a simplified diagnostic algorithm for deep vein thrombosis

TRanEXamic acid to decrease Heavy Menstrual Bleeding in individuals anticoagulated for venous thromboembolism (T-REX HMB): Health care practitioner survey.

EPCAT III - Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban and Aspirin to Aspirin Alone Following Total Hip and Knee Arthroplasty

Frequent collaborators

Marc Carrier

Sam Schulman

Vicky Tagalakis

Grégoire Le Gal

James Demetrios Douketis

Alejandro Lazo-Langner

Peter Lawrence Gross

Marc Rodger

Donald Arnold

Tzu-Fei Wang

Na Li

Frederick Spencer

Shannon Bates

Sudeep Shivakumar

Venkatesh Thiruganasambandamoorthy

Dimitrios Scarvelis

Ryan Zarychanski

Mark Crowther

Susan Kahn

Kerstin de Wit

Kerstin de Wit

Timothy Ramsay

Nancy Heddle

Alfonso Iorio

Sameer Parpia

Summer Syed

Kimberly Legault

David Anderson

Marc Rodger

Emily Rimmer

Eric Bohm

Tony Reiman

Na Li

Raman Mundi

Marc Afilalo

Caroline Hamm

Miriam Kimpton

Glenwood Goss

Leslie Skeith

Versha Banerji